Mendota Financial Group LLC trimmed its stake in Molina Healthcare, Inc. (NYSE:MOH – Free Report) by 24.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 435 shares of the company’s stock after selling 137 shares during the period. Mendota Financial Group LLC’s holdings in Molina Healthcare were worth $127,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of MOH. True Wealth Design LLC raised its holdings in shares of Molina Healthcare by 2,500.0% in the third quarter. True Wealth Design LLC now owns 104 shares of the company’s stock valued at $36,000 after buying an additional 100 shares during the last quarter. Ashton Thomas Private Wealth LLC bought a new position in shares of Molina Healthcare in the second quarter worth about $40,000. Versant Capital Management Inc lifted its position in shares of Molina Healthcare by 83.1% during the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company’s stock worth $47,000 after purchasing an additional 74 shares in the last quarter. Capital Performance Advisors LLP bought a new stake in shares of Molina Healthcare during the third quarter valued at approximately $62,000. Finally, UMB Bank n.a. increased its holdings in shares of Molina Healthcare by 96.2% in the third quarter. UMB Bank n.a. now owns 206 shares of the company’s stock valued at $71,000 after purchasing an additional 101 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Molina Healthcare Trading Up 3.0 %
NYSE MOH opened at $294.53 on Tuesday. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.54 and a quick ratio of 1.55. The stock’s 50-day moving average is $300.38 and its 200-day moving average is $317.32. Molina Healthcare, Inc. has a one year low of $272.69 and a one year high of $423.92. The firm has a market cap of $16.85 billion, a P/E ratio of 14.96, a P/E/G ratio of 1.04 and a beta of 0.54.
Analyst Ratings Changes
A number of brokerages have commented on MOH. StockNews.com upgraded Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, October 18th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $350.00 price objective (down from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. Truist Financial reduced their target price on shares of Molina Healthcare from $400.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Cantor Fitzgerald reissued an “overweight” rating and set a $406.00 price target on shares of Molina Healthcare in a research note on Thursday, October 24th. Finally, Robert W. Baird reduced their price objective on shares of Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $359.18.
View Our Latest Stock Analysis on MOH
About Molina Healthcare
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also
- Five stocks we like better than Molina Healthcare
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Is a Ford Stock Turnaround on the Horizon?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- What PMI Data Says About the NFP Report: 3 Hidden Opportunities
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Cintas: Trade Uncertainty Creates a Buy-the-Dip Opportunity
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.